Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mood Disorder Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Medications
1.2.3 Psychotherapy
1.2.4 Brain Stimulation Therapies
1.3 Market by Application
1.3.1 Global Mood Disorder Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Mood Disorder Treatment Market Perspective (2018-2033)
2.2 Mood Disorder Treatment Growth Trends by Region
2.2.1 Global Mood Disorder Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Mood Disorder Treatment Historic Market Size by Region (2018-2023)
2.2.3 Mood Disorder Treatment Forecasted Market Size by Region (2024-2033)
2.3 Mood Disorder Treatment Market Dynamics
2.3.1 Mood Disorder Treatment Industry Trends
2.3.2 Mood Disorder Treatment Market Drivers
2.3.3 Mood Disorder Treatment Market Challenges
2.3.4 Mood Disorder Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Mood Disorder Treatment Players by Revenue
3.1.1 Global Top Mood Disorder Treatment Players by Revenue (2018-2023)
3.1.2 Global Mood Disorder Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Mood Disorder Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Mood Disorder Treatment Revenue
3.4 Global Mood Disorder Treatment Market Concentration Ratio
3.4.1 Global Mood Disorder Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mood Disorder Treatment Revenue in 2022
3.5 Mood Disorder Treatment Key Players Head office and Area Served
3.6 Key Players Mood Disorder Treatment Product Solution and Service
3.7 Date of Enter into Mood Disorder Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Mood Disorder Treatment Breakdown Data by Type
4.1 Global Mood Disorder Treatment Historic Market Size by Type (2018-2023)
4.2 Global Mood Disorder Treatment Forecasted Market Size by Type (2024-2033)
5 Mood Disorder Treatment Breakdown Data by Application
5.1 Global Mood Disorder Treatment Historic Market Size by Application (2018-2023)
5.2 Global Mood Disorder Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Mood Disorder Treatment Market Size (2018-2033)
6.2 North America Mood Disorder Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Mood Disorder Treatment Market Size by Country (2018-2023)
6.4 North America Mood Disorder Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Mood Disorder Treatment Market Size (2018-2033)
7.2 Europe Mood Disorder Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Mood Disorder Treatment Market Size by Country (2018-2023)
7.4 Europe Mood Disorder Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Mood Disorder Treatment Market Size (2018-2033)
8.2 Asia-Pacific Mood Disorder Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Mood Disorder Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Mood Disorder Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Mood Disorder Treatment Market Size (2018-2033)
9.2 Latin America Mood Disorder Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Mood Disorder Treatment Market Size by Country (2018-2023)
9.4 Latin America Mood Disorder Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Mood Disorder Treatment Market Size (2018-2033)
10.2 Middle East & Africa Mood Disorder Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Mood Disorder Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Mood Disorder Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 MECTA Corporation
11.1.1 MECTA Corporation Company Detail
11.1.2 MECTA Corporation Business Overview
11.1.3 MECTA Corporation Mood Disorder Treatment Introduction
11.1.4 MECTA Corporation Revenue in Mood Disorder Treatment Business (2018-2023)
11.1.5 MECTA Corporation Recent Development
11.2 Ectron Limited
11.2.1 Ectron Limited Company Detail
11.2.2 Ectron Limited Business Overview
11.2.3 Ectron Limited Mood Disorder Treatment Introduction
11.2.4 Ectron Limited Revenue in Mood Disorder Treatment Business (2018-2023)
11.2.5 Ectron Limited Recent Development
11.3 Somatics, LLC.
11.3.1 Somatics, LLC. Company Detail
11.3.2 Somatics, LLC. Business Overview
11.3.3 Somatics, LLC. Mood Disorder Treatment Introduction
11.3.4 Somatics, LLC. Revenue in Mood Disorder Treatment Business (2018-2023)
11.3.5 Somatics, LLC. Recent Development
11.4 Alkermes
11.4.1 Alkermes Company Detail
11.4.2 Alkermes Business Overview
11.4.3 Alkermes Mood Disorder Treatment Introduction
11.4.4 Alkermes Revenue in Mood Disorder Treatment Business (2018-2023)
11.4.5 Alkermes Recent Development
11.5 Eli Lilly and Company
11.5.1 Eli Lilly and Company Company Detail
11.5.2 Eli Lilly and Company Business Overview
11.5.3 Eli Lilly and Company Mood Disorder Treatment Introduction
11.5.4 Eli Lilly and Company Revenue in Mood Disorder Treatment Business (2018-2023)
11.5.5 Eli Lilly and Company Recent Development
11.6 Janssen Global Services, LLC (Johnson & Johnson)
11.6.1 Janssen Global Services, LLC (Johnson & Johnson) Company Detail
11.6.2 Janssen Global Services, LLC (Johnson & Johnson) Business Overview
11.6.3 Janssen Global Services, LLC (Johnson & Johnson) Mood Disorder Treatment Introduction
11.6.4 Janssen Global Services, LLC (Johnson & Johnson) Revenue in Mood Disorder Treatment Business (2018-2023)
11.6.5 Janssen Global Services, LLC (Johnson & Johnson) Recent Development
11.7 Allergan (AbbVie Inc.)
11.7.1 Allergan (AbbVie Inc.) Company Detail
11.7.2 Allergan (AbbVie Inc.) Business Overview
11.7.3 Allergan (AbbVie Inc.) Mood Disorder Treatment Introduction
11.7.4 Allergan (AbbVie Inc.) Revenue in Mood Disorder Treatment Business (2018-2023)
11.7.5 Allergan (AbbVie Inc.) Recent Development
11.8 Pfizer Inc.
11.8.1 Pfizer Inc. Company Detail
11.8.2 Pfizer Inc. Business Overview
11.8.3 Pfizer Inc. Mood Disorder Treatment Introduction
11.8.4 Pfizer Inc. Revenue in Mood Disorder Treatment Business (2018-2023)
11.8.5 Pfizer Inc. Recent Development
11.9 Mylan N.V.
11.9.1 Mylan N.V. Company Detail
11.9.2 Mylan N.V. Business Overview
11.9.3 Mylan N.V. Mood Disorder Treatment Introduction
11.9.4 Mylan N.V. Revenue in Mood Disorder Treatment Business (2018-2023)
11.9.5 Mylan N.V. Recent Development
11.10 Novartis AG
11.10.1 Novartis AG Company Detail
11.10.2 Novartis AG Business Overview
11.10.3 Novartis AG Mood Disorder Treatment Introduction
11.10.4 Novartis AG Revenue in Mood Disorder Treatment Business (2018-2023)
11.10.5 Novartis AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Mood Disorder Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Medications
Table 3. Key Players of Psychotherapy
Table 4. Key Players of Brain Stimulation Therapies
Table 5. Global Mood Disorder Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Mood Disorder Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Mood Disorder Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Mood Disorder Treatment Market Share by Region (2018-2023)
Table 9. Global Mood Disorder Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Mood Disorder Treatment Market Share by Region (2024-2033)
Table 11. Mood Disorder Treatment Market Trends
Table 12. Mood Disorder Treatment Market Drivers
Table 13. Mood Disorder Treatment Market Challenges
Table 14. Mood Disorder Treatment Market Restraints
Table 15. Global Mood Disorder Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Mood Disorder Treatment Market Share by Players (2018-2023)
Table 17. Global Top Mood Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mood Disorder Treatment as of 2022)
Table 18. Ranking of Global Top Mood Disorder Treatment Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Mood Disorder Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Mood Disorder Treatment Product Solution and Service
Table 22. Date of Enter into Mood Disorder Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Mood Disorder Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Mood Disorder Treatment Revenue Market Share by Type (2018-2023)
Table 26. Global Mood Disorder Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Mood Disorder Treatment Revenue Market Share by Type (2024-2033)
Table 28. Global Mood Disorder Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Mood Disorder Treatment Revenue Market Share by Application (2018-2023)
Table 30. Global Mood Disorder Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Mood Disorder Treatment Revenue Market Share by Application (2024-2033)
Table 32. North America Mood Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Mood Disorder Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Mood Disorder Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Mood Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Mood Disorder Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Mood Disorder Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Mood Disorder Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Mood Disorder Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Mood Disorder Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Mood Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Mood Disorder Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Mood Disorder Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Mood Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Mood Disorder Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Mood Disorder Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 47. MECTA Corporation Company Detail
Table 48. MECTA Corporation Business Overview
Table 49. MECTA Corporation Mood Disorder Treatment Product
Table 50. MECTA Corporation Revenue in Mood Disorder Treatment Business (2018-2023) & (US$ Million)
Table 51. MECTA Corporation Recent Development
Table 52. Ectron Limited Company Detail
Table 53. Ectron Limited Business Overview
Table 54. Ectron Limited Mood Disorder Treatment Product
Table 55. Ectron Limited Revenue in Mood Disorder Treatment Business (2018-2023) & (US$ Million)
Table 56. Ectron Limited Recent Development
Table 57. Somatics, LLC. Company Detail
Table 58. Somatics, LLC. Business Overview
Table 59. Somatics, LLC. Mood Disorder Treatment Product
Table 60. Somatics, LLC. Revenue in Mood Disorder Treatment Business (2018-2023) & (US$ Million)
Table 61. Somatics, LLC. Recent Development
Table 62. Alkermes Company Detail
Table 63. Alkermes Business Overview
Table 64. Alkermes Mood Disorder Treatment Product
Table 65. Alkermes Revenue in Mood Disorder Treatment Business (2018-2023) & (US$ Million)
Table 66. Alkermes Recent Development
Table 67. Eli Lilly and Company Company Detail
Table 68. Eli Lilly and Company Business Overview
Table 69. Eli Lilly and Company Mood Disorder Treatment Product
Table 70. Eli Lilly and Company Revenue in Mood Disorder Treatment Business (2018-2023) & (US$ Million)
Table 71. Eli Lilly and Company Recent Development
Table 72. Janssen Global Services, LLC (Johnson & Johnson) Company Detail
Table 73. Janssen Global Services, LLC (Johnson & Johnson) Business Overview
Table 74. Janssen Global Services, LLC (Johnson & Johnson) Mood Disorder Treatment Product
Table 75. Janssen Global Services, LLC (Johnson & Johnson) Revenue in Mood Disorder Treatment Business (2018-2023) & (US$ Million)
Table 76. Janssen Global Services, LLC (Johnson & Johnson) Recent Development
Table 77. Allergan (AbbVie Inc.) Company Detail
Table 78. Allergan (AbbVie Inc.) Business Overview
Table 79. Allergan (AbbVie Inc.) Mood Disorder Treatment Product
Table 80. Allergan (AbbVie Inc.) Revenue in Mood Disorder Treatment Business (2018-2023) & (US$ Million)
Table 81. Allergan (AbbVie Inc.) Recent Development
Table 82. Pfizer Inc. Company Detail
Table 83. Pfizer Inc. Business Overview
Table 84. Pfizer Inc. Mood Disorder Treatment Product
Table 85. Pfizer Inc. Revenue in Mood Disorder Treatment Business (2018-2023) & (US$ Million)
Table 86. Pfizer Inc. Recent Development
Table 87. Mylan N.V. Company Detail
Table 88. Mylan N.V. Business Overview
Table 89. Mylan N.V. Mood Disorder Treatment Product
Table 90. Mylan N.V. Revenue in Mood Disorder Treatment Business (2018-2023) & (US$ Million)
Table 91. Mylan N.V. Recent Development
Table 92. Novartis AG Company Detail
Table 93. Novartis AG Business Overview
Table 94. Novartis AG Mood Disorder Treatment Product
Table 95. Novartis AG Revenue in Mood Disorder Treatment Business (2018-2023) & (US$ Million)
Table 96. Novartis AG Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Mood Disorder Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Mood Disorder Treatment Market Share by Type: 2022 VS 2033
Figure 3. Medications Features
Figure 4. Psychotherapy Features
Figure 5. Brain Stimulation Therapies Features
Figure 6. Global Mood Disorder Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Mood Disorder Treatment Market Share by Application: 2022 VS 2033
Figure 8. Hospital Case Studies
Figure 9. Specialty Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Mood Disorder Treatment Report Years Considered
Figure 12. Global Mood Disorder Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Mood Disorder Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Mood Disorder Treatment Market Share by Region: 2022 VS 2033
Figure 15. Global Mood Disorder Treatment Market Share by Players in 2022
Figure 16. Global Top Mood Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mood Disorder Treatment as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Mood Disorder Treatment Revenue in 2022
Figure 18. North America Mood Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Mood Disorder Treatment Market Share by Country (2018-2033)
Figure 20. United States Mood Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Mood Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Mood Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Mood Disorder Treatment Market Share by Country (2018-2033)
Figure 24. Germany Mood Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Mood Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Mood Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Mood Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Mood Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Mood Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Mood Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Mood Disorder Treatment Market Share by Region (2018-2033)
Figure 32. China Mood Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Mood Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Mood Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Mood Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Mood Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Mood Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Mood Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Mood Disorder Treatment Market Share by Country (2018-2033)
Figure 40. Mexico Mood Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Mood Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Mood Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Mood Disorder Treatment Market Share by Country (2018-2033)
Figure 44. Turkey Mood Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Mood Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. MECTA Corporation Revenue Growth Rate in Mood Disorder Treatment Business (2018-2023)
Figure 47. Ectron Limited Revenue Growth Rate in Mood Disorder Treatment Business (2018-2023)
Figure 48. Somatics, LLC. Revenue Growth Rate in Mood Disorder Treatment Business (2018-2023)
Figure 49. Alkermes Revenue Growth Rate in Mood Disorder Treatment Business (2018-2023)
Figure 50. Eli Lilly and Company Revenue Growth Rate in Mood Disorder Treatment Business (2018-2023)
Figure 51. Janssen Global Services, LLC (Johnson & Johnson) Revenue Growth Rate in Mood Disorder Treatment Business (2018-2023)
Figure 52. Allergan (AbbVie Inc.) Revenue Growth Rate in Mood Disorder Treatment Business (2018-2023)
Figure 53. Pfizer Inc. Revenue Growth Rate in Mood Disorder Treatment Business (2018-2023)
Figure 54. Mylan N.V. Revenue Growth Rate in Mood Disorder Treatment Business (2018-2023)
Figure 55. Novartis AG Revenue Growth Rate in Mood Disorder Treatment Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed